Download citation
Download citation

link to html
Two new symmetric double-armed oxa­diazole-bridged ligands, 4-methyl-{5-[5-methyl-2-(pyridin-3-yl­carbon­yl­oxy)­phen­yl]-1,3,4-oxa­diazol-2-yl}phenyl pyridine-3-carboxyl­ate (L1) and 4-methyl-{5-[5-methyl-2-(pyridin-4-yl­carbon­yl­oxy)­phen­yl]-1,3,4-oxa­diazol-2-yl}phenyl pyridine-4-carboxyl­ate (L2), were prepared by the reaction of 2,5-bis­(2-hy­droxy-5-methyl­phen­yl)-1,3,4-oxa­diazole with nicotinoyl chloride and iso­nicotinoyl chloride, respectively. Ligand L1 can be used as an organic clip to bind CuII cations and generate a mol­ecular complex, bis­(4-methyl-{5-[5-methyl-2-(pyridin-3-yl­carbon­yl­oxy)phen­yl]-1,3,4-oxa­diazol-2-yl}phenyl pyridine-3-carboxyl­ate)bis­(perchlorato)­copper(II), [Cu(ClO4)2(C28H20N4O5)2], (I). In com­pound (I), the CuII cation is located on an inversion centre and is hexa­coordinated in a distorted octa­hedral geometry, with the pyridine N atoms of two L1 ligands in the equatorial positions and two weakly coordinating perchlorate counter-ions in the axial positions. The two arms of the L1 ligands bend inward and converge at the CuII coordination point to give rise to a spirometallocycle. Ligand L2 binds CuI cations to generate a supra­molecule, diaceto­nitrile­di-[mu]3-iodido-di-[mu]2-iodido-bis­(4-methyl-{5-[5-methyl-2-(pyridin-4-yl­carbon­yl­oxy)­phen­yl]-1,3,4-oxa­diazol-2-yl}phenyl pyridine-4-carboxyl­ate)tetracopper(I), [Cu4I4(CH3CN)2(C28H20N4O5)2], (II). The asymmetric unit of (II) indicates that it contains two CuI atoms, one L2 ligand, one aceto­nitrile ligand and two iodide ligands. Both of the CuI atoms are four-coordinated in an approximately tetra­hedral environment. The molecule is centrosymmetric and the four I atoms and four CuI atoms form a rope-ladder-type [Cu4I4] unit. Discrete units are linked into one-dimensional chains through [pi]-[pi] inter­actions.
Follow Acta Cryst. C
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds